Accessibility: Skip TopNav
Positive Topline Results in Phase 2 STRIVE Parts A and B Clinical Trial
Rezafungin met its objectives for efficacy, safety and tolerability
Format
JPEG
Source
Cidara Therapeutics, Inc.
Downloads
Original
Large
Medium
Small